Details of the Drug Formulaction

General Information of Drug Formulation (ID: F23917)

• Formulation Name: Terconazole 80 mg Vaginal Suppository
• Company: Janssen Pharms

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Terconazole	(DMJ13KI)	Candidiasis	1F23	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Butylhydroxyanisole	(E00308)	24667	Antimicrobial preservative; Antioxidant
Lauric acid	(E00071)	3893	Antifoaming agent; Emulsifying agent; Lubricant; Penetration agent; Surfactant
Medium-chain triglyceride	(E00640)	Not Available	Emollient; Lubricant; Surfactant